|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.9 TWD | -12.30% |
|
-27.03% | -59.88% |
| Apr. 18 | UBI Pharma Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 2023 | UBI Pharma Inc. Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
UBI Pharma Inc. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was TWD 335.73 million compared to TWD 319.02 million a year ago. Net income was TWD 13.84 million compared to TWD 19.34 million a year ago.
Basic earnings per share from continuing operations was TWD 0.1155 compared to TWD 0.1732 a year ago. Diluted earnings per share from continuing operations was TWD 0.1155 compared to TWD 0.1732 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -59.88% | 50.36M | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
UBI PHARMA INC. 
